Clinical Trials Directory

Trials / Unknown

UnknownNCT01162902

Comparison of Vascular Remodeling Between Different Antianginal Medication Evaluated by Noninvasive ECG-gated Fundus Photographic Evaluation

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
150 (estimated)
Sponsor
Seoul National University Hospital · Academic / Other
Sex
All
Age
30 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Treatments for stable angina includes drug therapy such as calcium-channel blocker, beta blocker, and ACEI/ARB. To obtain good prognosis in patients with coronary artery disease,preventing or correcting the progression of atherosclerosis and dyslipidemia is more important than relieving angina symptom. Dysfunction of microvessel is one of the most important factor in patients with coronary artery disease. Recently, we developed the new non-invasive method of evaluating the microvessel in fundus. With this methods, we will compare the effect of each drug (beta blocker, CCB, ARB).

Conditions

Interventions

TypeNameDescription
DRUGDiltiazem treated groupDiltiazem 180mg for 9 months
DRUGBisoprolol treated groupBisoprolol 5mg for 9 months
DRUGCandesartan treated groupCandesartan 32mg for 9 months

Timeline

Start date
2013-09-01
Primary completion
2015-01-01
Completion
2015-12-01
First posted
2010-07-15
Last updated
2013-12-17

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT01162902. Inclusion in this directory is not an endorsement.